Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Relapsed Multiple Myeloma
NCT00514137Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in multiple myeloma (MM), sponsored by National Cancer Institute. Started Sep 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00514137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514137.